The twenty-first century is beginning with a sharp turn in the field of cancer therapy.
Molecular targeted therapies against specific oncogenic events are now possible. The BCR …

抄録< jats: p> The twenty-first century is beginning with a sharp turn in the field of cancer
therapy. Molecular targeted therapies against specific oncogenic events are now possible …

The twenty-first century is beginning with a sharp turn in the field of cancer therapy.
Molecular targeted therapies against specific oncogenic events are now possible. The BCR …

The twenty-first century is beginning with a sharp turn in the field of cancer therapy.
Molecular targeted therapies against specific oncogenic events are now possible. The BCR …

In 1845, the pathologists Bennet, Craigie, and Virchow independently described the disease
chronic myelogenous leukemia (CML)(1–3). In 1960, a major clue to the cause of CML was …

The twenty-first century is beginning with a sharp turn in the field of cancer therapy.
Molecular targeted therapies against specific oncogenic events are now possible. The BCR …

The BCR-ABL story : bench to bedside and back | CiNii Research CiNii 国立情報学研究所 学術
情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす 大学図書館の本を …